vania-janet/multiturn-rag-retrieval-data huggingface dataset:
Coronavirus FAQs: What Veterans Need To Know | Veterans Affairs
For questions about your prescriptions, send a secure message to your health care team through My HealtheVet. You can also call your local VA medical center.
Send a secure message to ask your care team about your prescriptions

 How can I get more refills for my prescriptions? 
 

You can request a prescription renewal in one of these ways:

Call the number on your prescription label. Be sure to have your Rx number from the prescription label and Social Security number ready. For some medications, your health care team may need to contact you before you can get more medication.
Get your Rx number
Send a secure message to your VA provider
Call your local VA medical center.
Find a VA location to renew your prescription

If your prescription renewal requires an in-person evaluation
If you need to renew a prescription for a medication that requires an in-person evaluation, we’ve temporarily updated our policy to allow this type of evaluation through telehealth (phone or video) appointment.
To request a telehealth appointment for a prescription renewal, send a secure message to your provider.
Send  your VA provider a secure message to request a telehealth appointment

VA health care eligibility and copays

 Do I have to pay VA health care copayments at this time? 
 

We canceled and refunded copayments for all medical care and pharmacy services received through VA between April 6, 2020, and September 30, 2021. We also paused collection of unpaid copayments for services or medications received before April 6, 2020, during this time. We took these actions to offer relief during the COVID-19 pandemic.
As of October 1, 2021, we’ve started to collect copayments again. We continue to offer financial hardship assistance. If you have questions, contact our Health Resource Center at 866-400-1238 (TTY: 711). We’re here Monday through Friday, 8:00 a.m. to 8:00 p.m. ET.
Find out how to pay your copay bill or request help
Get answers to more questions about COVID-19 medical debt relief
Información para entender cómo actúan las vacunas contra el COVID-19 | CDC
PDF de una infografía que explica cómo actúan las vacunas de ARNm contra el COVID-19.

Inglés [128 KB, 1 página]
Otros idiomas

Vacunas de subunidades proteicas (Novavax)
Las vacunas con subunidades de proteínas contienen partes (proteínas) del virus que causa el COVID-19. Estas partes del virus son la proteína S. La vacuna también contiene otro ingrediente llamado coadyuvante que ayuda al sistema inmunitario a responder a la proteína S en el futuro. Cuando el sistema inmunitario sepa cómo responder a la proteína S, el sistema inmunitario podrá responder rápidamente a la proteína S del virus real y protegerlo contra el COVID-19.
Acerca de Novavax
Investigaciones sobre tecnología de subunidades proteicas
Las vacunas de subunidades de proteínas se usan desde hace años.

Hace más de 30 años, la vacuna contra la hepatitis B fue la primera vacuna de subunidades de proteínas que recibió aprobación para administrar a personas en los Estados Unidos.
Otro ejemplo de otras vacunas de subunidades proteicas que se utilizan hoy en día incluyen la vacuna contra la tos ferina.

Cómo actúan las vacunas contra el COVID-19 de subunidades de proteínas

Las vacunas de subunidades proteicas contra el COVID-19 se administran en el músculo de la parte superior del brazo. Después de la vacunación, las células cercanas recogen estas proteínas.
Long COVID
Additionally, Governor Hochul also launched new, online education opportunities to help workers who believe they contracted COVID-19 due to an exposure at work, especially those suffering from ongoing long COVID symptoms. A new series of webinars - offered through the New York State Workers' Compensation Board - will provide information on workers' rights when it comes to filing a workers' compensation claim and the cash and/or medical benefits they may be eligible to receive. More information is available here. Long COVID can be considered a disability under the Americans with Disabilities Act (ADA).
NYSDOH will continue to communicate openly with New Yorkers as we learn more and work with public health authorities, specialists, and clinicians on ensuring that those living with long COVID can access the treatment, support, and care they need.

Resources

NYSDOH Resources, Media & Events

Frequently Asked Questions - Audio Format
NYS Insurance Fund Report: Long-term Impacts of COVID-19 (PDF)
NYS Insurance Fund Press Release: Report on Long-term Impacts of COVID-19
Consortium on Long COVID
Video, Transcript and Panelist Information for New York State Department of Health’s Expert Consortium to Address Long COVID
Rush Transcript Dr. Mary T. Bassett's introductory remarks at Long COVID Consortium
Governor Hochul and New York State Department of Health Announce an Expert Consortium to Address Long COVID
Governor Hochul Announces New Resources to Aid Workers with Long-Haul COVID-19 Workers' Compensation Claims
MIS-C page

Additional Resources

Information for Workers - NYS Workers' Compensation Board
Healthcare Appointment Checklist for Post-COVID Conditions (CDC)

Spanish (CDC)

Preparing to Discuss Post-COVID Conditions with a Healthcare Provider (CDC)

Spanish (CDC)

World Health Organization (WHO)
Long COVID (HHS)
Long COVID or Post-COVID Conditions (CDC)
Guidance on Long COVID as a Disability Under the ADA, Section 504, and Section 1557 (HHS)
NYC Long COVID Resource Center (NYC Health + Hospitals)

Provider Resources

Caring for People with Post-COVID Conditions (CDC)
Post-COVID Conditions: Information for Healthcare Providers (CDC)
Frequently Asked Questions | Department of Health
Frequently Asked Questions | Department of Health

 Skip to main content
 

 Your browser does not support iFrames
 

Navigation Menu Toggle

 COVID-19

VaccineVaccineVaccine Safety Vaccine for ChildrenVaccine for Pregnant New YorkersFAQsTestingTreatmentPrevention & SymptomsDataProvidersProvidersOral AntiviralsMonoclonal Antibody TherapeuticsVaccine InformationGuidanceNews

COVID-19 Vaccine

Frequently Asked Questions

 Find answers to frequently asked questions about the COVID-19 vaccine.

TOP
Frequently Asked Questions

SHARE

Share by Email

Share by Facebook

Share by Twitter

Sections

See All

 Safety and Effectiveness
 
 
 

Visit the CDC's webpage on COVID-19 Vaccine safety.Is the vaccine safe and effective?Yes. All COVID-19 vaccines in the United States are authorized for emergency use or approved by the Food and Drug Administration (FDA) and have been thoroughly tested and found to be safe and effective in preventing severe COVID-19. After a COVID-19 vaccine is authorized by the FDA, many vaccine safety monitoring systems watch for adverse events (possible side effects). This ongoing monitoring can pick up on adverse events that may not have been seen in clinical trials. If an unexpected adverse event is seen, experts quickly study it further to see if it is a true safety concern. Experts then decide whether changes are needed in US vaccine recommendations.Millions of people in the United States have received COVID-19 vaccines under the most intense safety monitoring in U.S. history.  Will the vaccine give me COVID?No. None of the approved vaccines are made up of materials that can cause disease. For example, the first vaccines authorized for emergency use by the FDA use a small, harmless part of the virus’s genetic material called ‘mRNA’. This is not the virus. mRNA vaccines teach your body to create virus proteins. Your immune system develops antibodies against these proteins that will help you fight the virus that causes COVID-19 if you are exposed to it. That is called an immune response. Are COVID vaccines safe for children?  Yes.
Covid-19 Vaccines


li><li><p><a href="/Programs/CID/DCDC/CDPH%20Document%20Library/COVID-19/COVID-19-Vaccination-Plan-California-Interim-Draft_V1.0.pdf" title="vaccination plan pdf">COVID-19 Vaccination Plan </a>(PDF) 10/16/2020<br></p></li><li><p><a href="/Programs/CID/DCDC/CDPH%20Document%20Library/COVID-19/Vaccine-Action-Plan.pdf" title="vaccine plan pdf">COVID-19 Vaccine Action Plan</a>  (PDF) 9/23/2021​​<br></p></li><li><p>​<a href="/Programs/CID/DCDC/Pages/COVID-19/ThirdVaccineDoseQandA.aspx">COVID-19 Vaccine Additional Doses Questions & Answers​</a> 6/13/2022​​​<br></p></li><li><p><a href="/Programs/CID/DCDC/Pages/COVID-19/COVID-19-Vaccine-Boosters.aspx">COVID-19 Vaccine Booster Doses​</a> 6/13/2023 </p></li><li><p><a href="/Programs/CID/DCDC/Pages/COVID-19/Vaccine-Booster-QA.aspx">​COVID-19 Vaccine Booster Questions and Answers</a> 6/13/2023 ​<br></p></li><li><p><a href="/Programs/CID/DCDC/Pages/COVID-19/COVID-19-Vaccine-Planning-Questions-and-Answers.aspx" title="Vaccine Plan Question and Answer">COVID-19 Vaccine Questions and Answers</a> 12/14/2020​​
Vacunas Contra El COVID-19 En VA | Veterans Affairs
Sí, puede vacunarse contra el COVID-19 y la gripe al mismo tiempo. Esto es lo que recomiendan los CDC:Si no ha recibido las dosis recomendadas actualmente de la vacuna contra el COVID-19, vacúnese contra el COVID-19 lo más pronto posible.Intente vacunarse contra la gripe antes de finales de octubre. La vacuna contra la gripe es una parte esencial para proteger su salud y la de su familia cada año.Nota: Solo los veteranos inscritos en el sistema de salud del VA pueden recibir la vacuna contra la gripe en los centros de salud del VA. Llame antes de acudir para asegurarse de que el centro dispone de ambas vacunas.Obtenga más información sobre las vacunas contra la gripe y el COVID-19 en el sitio web de los CDC

Cómo recibir la vacuna contra el COVID-19 en  VALe animamos a que se ponga al día con todas las vacunas recomendadas. Es la mejor manera de protegerse a sí mismo, a su familia y a su comunidad contra el COVID-19. Esto es de especial importancia ya que las nuevas formas (o “variantes”) del coronavirus se propagan con mayor rapidez en los Estados Unidos.Cómo recibir su dosis de la vacuna contra el COVID-19Ofrecemos vacunas contra el COVID-19 a todos los veteranos inscritos en el sistema de salud del VA y sonelegibles para recibir la vacuna contra el COVID- 19 con base en las recomendaciones de los CDC.Busque un centro de salud del VA que ofrezca un horario de atención sin cita previa en su respectiva clínica de vacunación contra el COVID-19.
Covid-19 Vaccines


<span style="color:#22252b;white-space:pre;font-size:24px !important;font-weight:bold !important;"><span style="color:#22252b;font-family:"inv maison neue", "maison neue", -apple-system, blinkmacsystemfont, "open sans", open-sans, sans-serif;white-space:pre;font-size:24px !important;font-weight:bold !important;"><strong>Call Your Local Public Health Department</strong></span></span></p><p><span style="color:#22252b;white-space:pre;font-size:24px !important;font-weight:bold !important;"><span style="color:#22252b;font-family:"inv maison neue", "maison neue", -apple-system, blinkmacsystemfont, "open sans", open-sans, sans-serif;white-space:pre;font-size:24px !important;font-weight:bold !important;"><strong></strong></span></span><span style="color:#22252b;font-family:"inv maison neue", "maison neue", -apple-system, blinkmacsystemfont, "open sans", open-sans, sans-serif;font-size:18px;white-space:pre;"><a href="/Pages/COVID-19-County-Offices.aspx" style="text-decoration:underline;">COVID-19 call lines</a> are available statewide.</span></p>Media RequestsMedia Requests<p>
Frequently Asked Influenza (Flu) Questions: 2019-2020 Season | CDC
Health Professionalsplus icon2023-24 ACIP Summaryplus iconBackground and Epidemiology23-24 ACIP TableVaccinationplus iconFlu Vaccines and PregnancyVaccine Dosage & AdministrationFor Clinicians: Vaccination SummaryFor Clinicians: Vaccine SafetyMake a Strong Flu Vaccine RecommendationTools to Prepare Your Practice for Flu SeasonInformation for Clinicians on Influenza Virus Testingplus iconClinical Guidance for Hospitalized and Non-Hospitalized Patients When SARS-CoV-2 and Influenza Viruses are Co-CirculatingClinical Guidance for Patients Being Hospitalized When SARS-CoV-2 and Influenza Viruses are Co-CirculatingClinical Guidance for Patients Not Being Hospitalized When SARS-CoV-2 and Influenza Viruses are Co-CirculatingOverview of Influenza Testing MethodsTesting and Management Considerations for Nursing Home Residents, SARS-CoV-2 and influenza virusesMultiplex Assays Authorized for Simultaneous Detection of Influenza Viruses and SARS-CoV-2Information on Collection of Respiratory Specimens for Influenza Virus TestingClinical Signs & Symptoms of InfluenzaInformation for Clinicians on Rapid Diagnostic Testing for InfluenzaRapid Influenza Diagnostic Tests (RIDTs)Guidance: Use of Rapid Diagnostic TestInformation on Rapid Molecular Assays, RT-PCR, and other Molecular Assays for Diagnosis of Influenza Virus InfectionNucleic Acid Detection Based TestsMedical Office Telephone EvaluationAlgorithm: Interpreting Influenza Testing Results When Influenza is CirculatingAlgorithm: Interpreting Influenza Testing Results When Influenza is NOT CirculatingGuide: Considering Influenza TestingGuide: Influenza Diagnostic Testing in Closed Setting OutbreaksInformation for Laboratoriesplus iconRapid Diagnostic TestingGuidance: Standard-Based Electronic Laboratory ReportingInfluenza Virus Testing MethodsAntiviral Drugsplus iconFor Clinicians: Antiviral MedicationTypes of Antiviral DrugsAntiviral Guidance Reference MaterialGuidance: Antiviral and Obstetric Health CareInfection Controlplus iconGuidelines for Healthcare SettingsGuidance: Outbreak Management in Long-Term Care FacilitiesGuidance: Use of Mask to Control Influenza TransmissionGuidance: Prevention & Control in Peri- and Postpartum SettingsFlu News & Spotlightsplus icon2023-20242022-20232021-20222020-20212019-2020What's New 

What CDC Does
Información para entender cómo actúan las vacunas contra el COVID-19 | CDC
Pero, con todos los tipos de vacunas el organismo se queda con un suministro de linfocitos T de "memoria", además de linfocitos B que recordarán cómo combatir ese virus en el futuro.
Por lo general, después de la vacunación el organismo demora algunas semanas en producir linfocitos T y linfocitos B.
A veces, después de la vacunación, el proceso de generar inmunidad puede causar síntomas, por ejemplo fiebre. Estos síntomas son signos normales que indica que el organismo está generando inmunidad.
Tipos de vacunas: de ARNm y de subunidades de proteínas
Datos acerca de las vacunas contra el COVID-19Hay diferentes tipos de vacunas. 

Todas las vacunas contra el COVID-19 hacen que nuestro organismo reconozca el virus que causa el COVID-19 y nos ayudan a protegernos.
Actualmente, hay dos tipos de vacunas contra el COVID-19 que se usan en los Estados Unidos: las vacunas de ARNmy las vacunas de subunidades de proteínas .

Ninguna de estas vacunas puede hacer que usted se enferme con el COVID-19.

No se usa ningún virus vivo para elaborar las vacunas.
Las vacunas no pueden causar infección por el virus que causa el COVID-19 ni por otros virus.

No afectan nuestro ADN ni interactúan con él.

Estas vacunas no ingresan al núcleo celular donde se encuentra nuestro ADN (material genético), así que no pueden modificar ni influir en nuestra genética.
How to Protect Yourself and Others | CDC
Overview and MethodsCOVID-19 Data SourcesForecastingplus iconHospital ForecastsVariant Surveillanceplus iconGenomic SurveillanceTracking VariantsHealthcare Workersplus iconClinical Careplus iconQuick ReferenceClinical Care ConsiderationsOutpatient Treatment OverviewUnderlying Medical ConditionsChildrenPost-COVID Conditions: Healthcare ProvidersPost-COVID Conditions: CDC ScienceTestingplus iconTesting OverviewAntibody TestingInfection Control Guidanceplus iconPostmortem GuidancePotential Exposure at WorkPandemic Planning ScenariosCOVID-19SurgeStaff ShortagesElectronic Case ReportingTrainingNon-US Healthcare Settingsplus iconCOVID-19 & IPC OverviewTriaging Sick PatientsOutpatient FacilitiesAdditional Tools and ResourcesLab Professionalsplus iconTestingplus iconAntigen Testing GuidelinesNucleic Acid Amplification TestsPoint-of-Care & Rapid TestingOther Diagnostic TestsFlu SARS-CoV-2 Multiplex AssayReporting Lab Dataplus iconReporting SARS-CoV-2 Sequencing ResultsBiosafety for Specimen HandlingSpecimen CollectionHealth Departmentsplus iconSurveillance & Data Analyticsplus iconReporting COVID-19 CasesElectronic Case ReportingCOVIDTracer & COVIDTracer AdvancedSprayers Safety PrecautionsCommunication Resourcesplus iconPrint ResourcesVideosPeople with Intellectual & Developmental Disabilitiesplus iconResources for People with IDDEasy to ReadBraille 

 email_03Get Email Updates To receive email updates about COVID-19, enter your email address: Email Address What's this? Submit 

About CDC
Contact Us
800-232-4636

Facebook
Twitter
Instagram
LinkedIn
Youtube
Pinterest
Snapchat


	CONTACT CDC
	

Contact Us

Call 800-232-4636

Email Us


	ABOUT CDC
	

About CDC
Jobs
Funding


	POLICIES
	

Accessibility
External Links
Privacy
Policies
No Fear Act
FOIA
OIG
Nondiscrimination
Vulnerability Disclosure Policy


	CONNECT WITH US
	

Facebook
Twitter
Instagram
LinkedIn

Youtube
Información para entender cómo actúan las vacunas contra el COVID-19 | CDC
Mirar video: Entender el rol del ACIP y cómo se llega a la recomendación de una vacuna [00:05:02]

Seguimiento de seguridad a través de sistemas de monitoreo de las vacunas

Cientos de millones de personas en los Estados Unidos se vacunaron contra el COVID-19 bajo el monitoreo de seguridad más exigente en la historia de los EE. UU.
Sigue habiendo varios sistemas de monitoreo de los resultados de las vacunas contra el COVID-19, para garantizar que sean seguras. Algunas personas no sufren efectos secundarios. Muchas personas han notificado efectos secundarios luego de vacunarse contra el COVID-19, como dolor o inflamación en la zona donde se aplicó la inyección, dolor de cabeza, escalofríos o fiebre. Estas reacciones son frecuentes y son signos normales de que su organismo está generando protección.
Es poco frecuente que se notifiquen reacciones adversas graves después de la vacunación.

Información acerca de vacunarse
¿Cómo puede prepararse para la vacunación?
¿Qué sucederá durante y después de su vacunación?
¿Sin cobertura de seguro? Igual puede vacunarse contra el COVID-19 en forma gratuita. Obtenga más información sobre el Programa para ampliar y garantizar el acceso gratis a la vacunación de los CDC.

Vacunarse contra el COVID-19
Recursos
Para atención médica y salud públicaRecursos clínicos y profesionales para el COVID-19
Más información
About COVID-19 Vaccines | Veterans Affairs
Scientists have been studying vaccines for more than 100 years. Scientists have been studying the technology for mRNA vaccines for more than 20 years. And the National Institutes of Health (NIH) was working on creating a coronavirus vaccine even before the COVID-19 pandemic.
They got the funding they needed to work quickly. The COVID-19 pandemic was a public health emergency. So the U.S. government invested millions of dollars to help study and test vaccines.
They used a faster review process with all the same steps. The FDA authorized the original COVID-19 vaccines under their Emergency Use Authorization (EUA). An EUA follows the same steps that full-term clinical trials take. This includes testing each vaccine on thousands of human participants. The only difference is that an EUA speeds up the FDA’s review process. This helps get critical vaccines to people faster while still making sure the vaccines are safe and that they work well.
They involved many experts in reviewing data. Independent groups also reviewed trial results to make sure the vaccines are safe. These include groups like the National Medical Association, the leading professional society of Black doctors.

The FDA continues to monitor COVID-19 vaccines even after they’re approved.
Play this FDA video to learn more about the EUA process (YouTube)

 It’s safe to get several vaccines in the same year 
 

Vaccines have pieces of germs or viruses, killed germs, or weakened germs in them.
The goal of a vaccine is to teach your immune system to make antibodies to fight off the real virus if you’re exposed to it. In the natural state, your body is exposed to thousands of germs. Your body then makes antibodies in response. Vaccines are a safer way for your body to learn to make antibodies to some of the more dangerous viruses, like COVID-19. But vaccines use the same natural process of your immune system, which is already activated often by germs and viruses. 
We know that COVID-19 vaccines work well to prevent severe illness and death from COVID-19. Scientists continue to study the effectiveness of the COVID-19 vaccines as new variants appear.
معلومات لمقدمي الخدمات | دائرة الصحة
جهة الاتصالبرجاء الاتصال بفريق COVID-19 Therapeutics في [ محمي بالبريد الالكتروني ] كان لديك أي أسئلة و / أو اهتمامات. 

 المضادات الحيوية المضادة للفيروسات (mAb)
 
 
 

وبدءا من أيلول / سبتمبر 2021 ، بدأت وزارة الصحة في ولاية نيويورك في إدارة عملية توزيع العلاجات المضادة للأجسام الأحادية النسيلة (م ب) داخل الدولة. لا يوجد منتج متوفر حاليًا. هناك بعض المنتجات التي تم توزيعها مسبقًا ولكنها غير مصرح بها حاليًا للاستخدام في نيويورك.
معلومات لمقدمي الخدمات | دائرة الصحة
أحقيةوقد أذنت الهيئة بوجود اثنين من العقاقير المضادة للفيروسات ، وهو باكزلوفيد و monnupifrir، لعلاج المصابين بمرض COVID-19 في بعض المرضى الذين : وقد اختبرت إيجابية بالنسبة ل COVID-19 وكان لديها أعراض لمدة 5 أيام أو أقل. معرضون بشكل كبير لخطر الانتقال إلى COVID-19 شدة ، بما في ذلك العلاج في المستشفيات أو الموت. قابل معايير معينة اعتمادا على المضاد الفيروسي.
معلومات لمقدمي الخدمات | دائرة الصحة
قامت إدارة الغذاء والدواء الأمريكية أيضًا بتوسيع الموافقة على Veklury (remdesivir) لتشمل مرضى الأطفال الذين تبلغ أعمارهم 28 يومًا أو أكثر والذين يزنون 3 كيلوغرامات على الأقل (حوالي 7 أرطال) مع نتائج إيجابية للاختبار الفيروسي المباشر لـ SARS-CoV-2 وهم: مستشفيات ، أو ولا يتلقى العلاج في المستشفى ولديه COVID-19 ، وهو معرض لخطر الانتقال إلى المبرد الحاد (COVID-19) ، بما في ذلك العلاج في المستشفيات أو الموت. وينبغي أن يناقش مقدمو الرعاية الصحية المخاطر والفوائد المترتبة على العلاج مع مرضاهم.
COVID-19 Overview and Infection Prevention and Control Priorities in non-U.S. Healthcare Settings | CDC
COVID-19 infection: the China and Italy perspectives. Cell Death Dis 11, 438 (2020). https://doi.org/10.1038/s41419-020-2603-0
WHO. Advise on the use of masks in the context of COVID-19. 5 June 2020.

Top of Page


	Last Updated Oct. 27, 2023	Source: 	National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases

Facebook
Twitter
LinkedIn
Syndicate

homeCOVID-19About COVID-19plus iconVariantsHow COVID-19 SpreadsReinfectionAnimals and COVID-19plus iconWildlifePetsToolkitHealth EquitySymptomsTestingMedical ConditionsPreventionplus iconMasksplus iconTypes of Masks and RespiratorsUse and Care of MasksHow to Use Your N95 RespiratorVentilationplus iconHome VentilationImproving Ventilation In BuildingsFacility Cleaning & Ventilationplus iconUpper-Room Ultraviolet Germicidal IrradiationVentilation in BuildingsSchool Ventilation ToolVaccinesplus iconStay Up to Date with VaccinesOverview of COVID-19 VaccinesHow COVID-19 Vaccines WorkYour Vaccinationplus iconWhen Getting Your VaccineSpecific Groups of PeopleSafety of COVID-19 Vaccinesplus iconAllergic ReactionsVaccine Safety in Children & TeensMyocarditis and PericarditisInvestigating MyocarditisReported Adverse EventsCOVID-19 Vaccine Effectivenessplus iconVaccine Effectiveness StudiesAbout COVID-19 Vaccinesplus iconFrequently Asked QuestionsBenefits of Getting VaccinatedMyths & FactsTreatments & MedicationsLong COVIDplus iconCaring for People with Long COVIDPatient Appointment TipsData & Surveillanceplus iconHospitalization Surveillance Network COVID-NETplus iconCOVID-NET DashboardCOVID-NET